Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Invesco | HDFC |
| NAV | ₹19.5700 | ₹23.6750 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.7 years | 3.1 years |
| Expense ratio | 1.3% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 27.90 | 94.50 |
Returns
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +9.21% | +12.97% |
| 3 months | +3.44% | +7.13% |
| 6 months | +14.91% | +17.84% |
| YTD | +4.71% | +33.73% |
| 1 year | +2.51% | +32.20% |
| 3 years (CAGR) | +10.71% | +30.70% |
| 5 years (CAGR) | +7.65% | — |
| 10 years (CAGR) | — | — |
| Since launch | +12.59% | +31.83% |
Risk
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 16.3% | 15.8% |
| Downside volatility | 11.5% | 8.5% |
| Sharpe | 0.26 | 1.53 |
| Sortino | 0.37 | 2.86 |
| Calmar | 0.48 | 2.06 |
| Return / risk | 0.66 | 1.95 |
| Deepest fall | −22.78% | −14.91% |
| Days to recover | 441 | 126 |
| Below its high | −2.20% | +0.00% |
Against benchmark
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +7.54% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 108.9% |
| Down capture | — | 71.0% |
| Tracking error | — | 6.1% |
| Information ratio | — | 1.17 |
| Treynor | — | 0.24 |
Consistency
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +42.52% | +67.01% |
| Middle 1-year | +6.06% | +23.25% |
| Worst 1-year | −12.65% | +1.71% |
| 1-year periods with a loss | 36.7% | 0.0% |
| Middle 3-year | +13.90% | +30.22% |
| Positive months | 63.9% | 72.2% |
| Best day | +4.25% | +3.18% |
| Worst day | −5.44% | −3.61% |
| Worst 5% day | −1.50% | −1.51% |
| Positive days | 53.1% | 58.3% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Invesco India ESG Integration Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +9.79% | — |
| 5-year value | ₹7,71,462 | — |
| 3-year XIRR | +6.79% | +27.71% |
| 1-year XIRR | +15.91% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.